BDBM475934 Preparation of (2S,6R,11R)-8-((4-(2,5,8,11,14-pentaoxahexadecan-16-ylamino)phenyl)amino)-3-(cyclopropylmethyl)-6,11-dimethyl-3,4,5,6-tetrahydro-2,6-methanobenzo[d]azocin-1(2H)-one ::US10865186, Compound 12

SMILES COCCOCCCCCOCCOCCNc1ccc(Nc2ccc3c(c2)[C@]2(C)CCN(CC4CC4)C(C3=O)[C@@H]2C)cc1

InChI Key InChIKey=CICHZWIBBWACSO-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 475934   

TargetKappa-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 475934BDBM475934(Preparation of (2S,6R,11R)-8-((4-(2,5,8,11,14-pent...)
Affinity DataKi:  5nMAssay Description:The binding affinities of certain compounds of the present invention were evaluated using radioligand binding assays in membranes prepared from CHO-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/18/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 475934BDBM475934(Preparation of (2S,6R,11R)-8-((4-(2,5,8,11,14-pent...)
Affinity DataKi:  58.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/18/2021
Entry Details
US Patent